Toxoplasmosis.
D001500:BCG Vaccine; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control; D011739:Pyrimethamine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000254:growth & development; D014123:Toxoplasmosis / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control; D014125:Toxoplasmosis, Congenital / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control
D001500:BCG Vaccine; D007933:Leucomycins; D013449:Sulfonamides; D011739:Pyrimethamine